Large-scale search for genes predisposing to essential hypertension.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 12559687)

Published in Am J Hypertens on February 01, 2003


Jean-Marc Lalouel

Associated clinical trials:

Family Blood Pressure Program - GenNet Network | NCT00005268

Articles by these authors

Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse. Hypertension (2002) 2.00

Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens (2012) 1.74

Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet (2004) 1.61

A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens (2005) 1.55

AGT genetic variation, plasma AGT, and blood pressure: An analysis of the Utah Genetic Reference Project pedigrees. Am J Hypertens (2010) 1.43

Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet (2001) 1.43

Common variant of human NEDD4L activates a cryptic splice site to form a frameshifted transcript. J Hum Genet (2002) 1.09

Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes. J Hypertens (2010) 0.97

Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens (2005) 0.94

Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status. J Hypertens (2005) 0.91

Haplotype association analysis of AGT variants with hypertension-related traits: the HyperGEN study. Hum Hered (2005) 0.86

Transcriptional diversity and expression of NEDD4L gene in distal nephron. Biochem Biophys Res Commun (2005) 0.81

A human polymorphism affects NEDD4L subcellular targeting by leading to two isoforms that contain or lack a C2 domain. BMC Cell Biol (2009) 0.80

From genetics to mechanism of disease liability. Adv Genet (2008) 0.78

Hypervolemia of pregnancy is not maintained in mice chronically overexpressing angiotensinogen. Am J Obstet Gynecol (2006) 0.77

Molecular cloning and functional analysis of a factor that binds to the proximal promoter of human angiotensinogen. J Hum Genet (2002) 0.77

Contribution of Sp1 to initiation of transcription of angiotensinogen. J Hum Genet (2002) 0.75

[Human angiotensinogen gene and its implication in essential hypertension]. Nihon Rinsho (2004) 0.75

A real-time, telemetric method for continuous measurement of portal pressures. J Surg Res (2009) 0.75